Literature DB >> 16258873

Fatal outcome of a hyperinfection syndrome despite successful eradication of Strongyloides with subcutaneous ivermectin.

H P Hauber1, J Galle, P L Chiodini, J Rupp, R Birke, E Vollmer, P Zabel, C Lange.   

Abstract

We report the case of a 77-year-old man who developed a Strongyloides hyperinfection syndrome following immunosuppressive therapy more than 60 years after he moved away from an area endemic for Strongyloides stercoralis. Successful eradication of the nematode was achieved with an off label subcutaneous formulation of ivermectin. However, the patient subsequently died from acute respiratory distress syndrome (ARDS). Despite a high wormload in the stool and sputum of the patient and delayed infection control measures in the hospital, testing of the medical staff revealed a very low risk of Strongyloides transmission among healthcare workers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16258873      PMCID: PMC7102170          DOI: 10.1007/s15010-005-5060-x

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  16 in total

1.  Non-oral treatment with ivermectin for disseminated strongyloidiasis.

Authors:  Dahlene N Fusco; Jennifer A Downs; Michael J Satlin; Meera Pahuja; Liz Ramos; Philip S Barie; Lawrence Fleckenstein; Henry W Murray
Journal:  Am J Trop Med Hyg       Date:  2010-10       Impact factor: 2.345

2.  Failure of ivermectin per rectum to achieve clinically meaningful serum levels in two cases of Strongyloides hyperinfection.

Authors:  Isaac I Bogoch; Kamran Khan; Howard Abrams; Caroline Nott; Elizabeth Leung; Lawrence Fleckenstein; Jay S Keystone
Journal:  Am J Trop Med Hyg       Date:  2015-04-27       Impact factor: 2.345

3.  Update on strongyloidiasis in the immunocompromised host.

Authors:  Luis A Marcos; Angélica Terashima; Marco Canales; Eduardo Gotuzzo
Journal:  Curr Infect Dis Rep       Date:  2011-02       Impact factor: 3.725

Review 4.  Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis.

Authors:  Rojelio Mejia; Thomas B Nutman
Journal:  Curr Opin Infect Dis       Date:  2012-08       Impact factor: 4.915

5.  Toxicity and potential utility of ivermectin and moxidectin as xenointoxicants against the common bed bug, Cimex lectularius L.

Authors:  Johnathan M Sheele; Gale E Ridge
Journal:  Parasitol Res       Date:  2016-04-18       Impact factor: 2.289

6.  Strongyloides stercoralis infection in the immunocompromised host.

Authors:  Roshan Ramanathan; Thomas Nutman
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

7.  Prevalence of Strongyloides stercoralis in an urban US AIDS cohort.

Authors:  Linda Nabha; Sonya Krishnan; Roshan Ramanathan; Rojelio Mejia; Gregg Roby; Virginia Sheikh; Isabel McAuliffe; Thomas Nutman; Irini Sereti
Journal:  Pathog Glob Health       Date:  2012-08       Impact factor: 2.894

Review 8.  Strongyloides stercoralis hyperinfection syndrome: a case series and a review of the literature.

Authors:  Guillaume Geri; Antoine Rabbat; Julien Mayaux; Lara Zafrani; Ludivine Chalumeau-Lemoine; Bertrand Guidet; Elie Azoulay; Frédéric Pène
Journal:  Infection       Date:  2015-05-26       Impact factor: 7.455

9.  CATMAT statement on disseminated strongyloidiasis: Prevention, assessment and management guidelines.

Authors:  A K Boggild; M Libman; C Greenaway; A E McCarthy
Journal:  Can Commun Dis Rep       Date:  2016-01-07

Review 10.  Severe strongyloidiasis: a systematic review of case reports.

Authors:  Dora Buonfrate; Ana Requena-Mendez; Andrea Angheben; Jose Muñoz; Federico Gobbi; Jef Van Den Ende; Zeno Bisoffi
Journal:  BMC Infect Dis       Date:  2013-02-08       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.